Green Thumb: Analyst Consensus Estimates For Q3 2021

Green Thumb Industries (CSE: GTII) announced that they will be reporting their third quarter financials after the markets close on November 10th.

Analysts have a consensus C$59.06 12-month price target on the company, via a total of 16 analysts, with 4 analysts having strong buy ratings, and the other 12 having buy ratings on the company. The street high comes from Stifel-GMP with an C$80 price target, and the lowest target comes from Roth Capital Partners with a C$40 price target.

15 analysts have revenue estimates for the third quarter. The mean between all 15 is US$233.33 million; this number has been revised slightly upwards from US$221.54 million at the start of May. The street high is US$250.60 million while the lowest sits at US$222.27 million.

Six analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 55.32%, with this number being flat at the start of May. Street high is 57% estimate and the lowest sits at 54%.

Onto EBITDA estimates, there are currently 14 analysts who have third-quarter EBITDA estimates. The mean is currently US$82.54 million, with this number being basically flat since the start of May. Street high sits at US$88.70 million EBITDA and the lowest being a US$78.23 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

The Biggest Undeveloped Gold Project Still Needs One Thing | Rudi Fronk – Seabridge

The Silver Market May Be Closer to Breaking Than It Looks | Andy Schectman

Recommended

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Canadian Gold Resources Taps Chernin as Interim CEO in Planned Transition

Related News

Canaccord Reiterates $1.75 Price Target For Mind Medicine Following Roadshow Event

This morning, Canaccord released a flash update for Mind Medicine (NEO: MMED) with highlights from...

Monday, September 28, 2020, 11:02:24 AM

Harvest Health: Canaccord, Stifel Raise Price Targets

Earlier this week, Harvest Health & Recreation (CSE: HARV) released its third quarter results. The...

Thursday, November 12, 2020, 03:57:03 PM

Canaccord Reiterates $6.00 Price Target On Valens Company Following Investor Day

This morning, Canaccord Genuity released their takeaway from hosting their first virtual investor day with...

Friday, November 20, 2020, 02:37:00 PM

Green Thumb CEO Ben Kovler Loses $52.5 Million Worth Of Shares As Part Of Divorce Settlement

It appears that a divorce has cost Green Thumb Industries’ (CSE: GTII) CEO Ben Kovler...

Tuesday, September 26, 2023, 10:49:49 PM

BMO Reiterates $21 Price Target On Victoria Gold After Production Results

On January 6th, Victoria Gold Corp. (TSX: VGCX) announced its fourth quarter and annual production...

Saturday, January 8, 2022, 01:08:00 PM